Pharmaceutical Companies
Sage Therapeutics
๐บ๐ธUnited States
Sage Potash Corp is engaged in the acquisition, exploration, and development of mineral properties. Its principal business activity is the acquisition, exploration, and development of potash mineral properties. It holds interest in Sage...
Emergent Biosolutions Inc.
๐บ๐ธUnited States
- Ownership
- Public
- Established
- 1998-01-01
- Employees
- 1.6K
- Market Cap
- $490.9M
SEQUENT SCIENTIFIC LIMITED
๐ฎ๐ณIndia
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $489.8M
- Website
- -
EyePoint Pharmaceuticals
๐บ๐ธUnited States
- Ownership
- Public
- Established
- 1987-01-01
- Employees
- 121
- Market Cap
- $486.4M
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the...
HIKAL
๐ฎ๐ณIndia
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $483.2M
- Website
- -
Medios AG
๐ฉ๐ชGermany
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $482.9M
- Website
- -
Alturas Minerals Corp
๐บ๐ธUnited States
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a...
Clinuvel Pharmaceuticals Ltd
๐ฆ๐บAustralia
- Ownership
- -
- Established
- -
- Employees
- 16
- Market Cap
- $473M
- Website
- -
Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief...
Verve Therapeutics
๐บ๐ธUnited States
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru,...
Neurogene
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- 91
- Market Cap
- $466.9M
- Website
- -
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
